investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Women's Interagency HIV Study (WIHS-V)
Kathryn Anastos
5 Collaborator(s)
Funding source
National Institute of Allergy and Infectious Diseases (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Kathryn Anastos
Yeshiva University
New York, United States
WE-ACTX
Kigali, Rwanda
Collaborator from Stony Brook University
Stony Brook University
Stony Brook, United States
Collaborator from Montefiore Medical Center
Montefiore Medical Center
The Bronx, United States
Walter Doerfler
University of Erlangen-Nuremberg
Erlangen, Germany
Rupert Kaul
University of Toronto
Toronto, Canada
Kathryn M Anastos
Yeshiva University
New York, United States
Related projects
Global Noncommunicable Diseases Intiatives
Cryotherapy market dynamics: Increasing access to treatment of HPV-related disease - 2
Cervix uteri
Global Noncommunicable Diseases Intiatives
Cervical Cancer Screening and Preventative Therapy via Reproductive Health Networks (CCS&PT) - 2
Cervix uteri
Mark H. Einstein
Expanded Phase II Trial of Carraguard for Prevention of HPV Infection
Cervix uteri
Global Noncommunicable Diseases Intiatives
Scaling of lessons and best practices from HPV demonstration programs
Cervix uteri
John A Bartlett
Developing Research Capacity in Africa for Studies on HIV-Associated Malignancies
Cervix uteri
Global Noncommunicable Diseases Intiatives
Centre for prevention of cervical cancer and infirmary for chemotherapeutic activities - 2
Cervix uteri
Michael Dean
Cancer and Inflammation Genetics
Cervix uteri
Pediatric oncology or childhood cancer
Pathology
Global Noncommunicable Diseases Intiatives
The START-UP Project: Screening Technologies to Advance Rapid Testing for Cervical Cancer Prevention-Utility and Program Planning - 4
Cervix uteri
Global Noncommunicable Diseases Intiatives
NHS Lothian: Developing a Sustainable Programme of Cervical Cancer Screening - 2
Cervix uteri